跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDE-DRLA lenalidomide 25 mg capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
LENALIDOMIDE-DRLA lenalidomide 25 mg capsule blister pack
Approved
STANDARD
LENALIDOMIDE-DRLA lenalidomide 25 mg capsule blister pack
Dr Reddys Laboratories Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
16f2c5ddd7e682c2
Company
Dr Reddys Laboratories Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
16f2c5ddd7e682c2
Product Name
LENALIDOMIDE-DRLA lenalidomide 25 mg capsule blister pack
Artg Id
294132
Artg Name
LENALIDOMIDE-DRLA lenalidomide 25 mg capsule blister pack
Sponsor
Dr Reddys Laboratories Australia Pty Ltd
Company Detail Path
/organization/dr-reddys-laboratories-australia-pty-ltd
Artg Date
2021-07-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
16f2c5ddd7e682c2
Type
Standard
Back to TGA Approvals
